Vast majority of vaping products fail to meet UK regulatory standards
Industry analysts warn that up to 90% of vaping products currently sold in the UK do not comply with existing regulations, with many retailers unknowingly distributing non-compliant items. New government rules taking effect on October 29 will ban sales to under-18s and restrict discounts on vaping products, though experts argue these measures do not adequately address the widespread problem of unlicensed and counterfeit vapes in the market. The vaping industry has called for clearer oversight of supply chains and distribution networks to ensure products meet minimum safety standards.
The UK vaping market faces a significant compliance crisis as new legislation takes effect. Beginning 29 October, retailers face stricter penalties including prohibition on under-18 sales and removal of promotional discounts. A mandatory duty stamp system launched 1 October aims to track legitimate products through the supply chain. However, enforcement challenges persist, particularly regarding counterfeit goods that enter distribution networks through multiple intermediaries before reaching retail shelves.
Industry insiders point to supply chain fragmentation as a root cause. Many retailers source from numerous distributors without full transparency about product origins, storage conditions, or manufacturing standards. This opacity creates vulnerability to non-compliant items entering legitimate shops unknowingly. The regulatory framework, while addressing youth access, has not adequately tackled the underlying infrastructure problems that allow substandard products to circulate widely.
This compliance failure could impact multiple stakeholders differently. Consumers may unknowingly purchase unsafe or counterfeit products, potentially facing health risks. Legitimate small retailers may face liability for selling non-compliant items without realisation, threatening their viability. Manufacturers operating within regulations may face unfair competition from unlicensed producers with lower costs. Broader public health outcomes could be undermined if youth access restrictions are ineffective when most available products lack proper compliance verification, potentially eroding confidence in regulatory oversight.